Summary Unsaturated fatty acids, including n-3 polyunsaturated fatty acids (PUFAs) such as docosahexaenoic acid (C225, DHA) and eicosapentaenoic acid (C20.5, EPA), and a series of n-6 PUFAs were investigated for their anti-tumour and antimetastatic effects in a subcutaneous (s.c.) implanted highly metastatic colon carcinoma 26 (Co 26Lu) model. EPA and DHA exerted significant inhibitory effects on tumour growth at the implantation site and significantly decreased the numbers of lung metastatic nodules. Oleic acid also significantly inhibited lung metastatic nodules. Treatment with arachidonic acid showed a tendency for reduction in colonization. However, treatment with high doses of fatty acids, especially linoleic acid, increased the numbers of lung metastatic nodules. DHA and EPA only inhibited lung colonizations when administered together with the tumour cells, suggesting that their incorporation is necessary for an influence to be exerted. Chromatography confirmed that contents of fatty acids in both tumour tissues and plasma were indeed affected by the treatments. Tumour cells pretreated with fatty acids in vivo, in particular DHA, also showed a low potential for lung colony formation when transferred to new hosts. Thus, DHA treatment exerted marked antimetastatic activity associated with pronounced change in the fatty acid component of tumour cells. The results indicate that uptake of DHA into tumour cells results in altered tumour cell membrane characteristics and a decreased ability to metastasize.
As tumour metastasis exerts an adverse influence on the prognosis of patients and is a major cause of cancer death, a considerable number of investigations into its biological, molecular and genetic features have been conducted (Raz and Ben-Ze'ev, 1987; Bertomeu et al, 1993) . These investigations have indicated that tumour metastases are established by an inter-related sequence of processes, depending on various factors derived from both the tumour and the host. There is substantial evidence that the membrane properties of tumour cells play a major role in the interactions between themselves and the surrounding environment (Awad and Spector, 1976; Schroeder, 1984; Taraboletti et al, 1989; Dahiya et al, 1992) . Studies on mice have revealed that plasma membranes of tumour sublines with high metastatic ability exhibit a more fluid state than those with low metastatic ability, based on differences in lipid composition and lipid-protein ratios (Kier and Franklin, 1991) . Furthermore, studies have demonstrated that the chemical and physical properties of cell membranes are modified by both the amount and type of fat in the diet, and this influences growth and/or alters the metastatic ability of tumour cells (Chen et al, 1992; Rose and Hatala, 1994) . Diets rich in linoleic acid have been found to enhance the growth and metastasis of transplantable mammary carcinomas in rodents (Rao and Abraham, 1976; . In a study of dietary n-3 PUFAs in a spontaneous model of mammary adenocarcinoma in rats, growth of primary tumours was significantly inhibited whereas there was no effect on metastasis (Kort et al, 1987) . In another study of human breast cancer in the athymic nude mouse, high-fat diets rich in n-3 fatty acid suppressed both growth and metastasis . In the described case, however, natural fats were mixed into the experimental diet as the source of PUFAs, and it was uncertain whether the effects of the experimental diets were linked to the main fatty acids and/or to the oxidized products of PUFAs yielded before the administration. The objective of the present study was to compare different PUFAs for their influence on the metastatic ability of colon carcinoma 26 (Co 26Lu) tumour, the highly metastatic murine colon carcinoma cell line that we recently established (ligo et al, 1994) , and to investigate the underlying mechanisms. For this purpose, we used highly purified PUFAs and took strict precautions against fatty acid oxidation before administration.
MATERIALS AND METHODS Chemicals
Ethyl esters of 9,12-octadecadienoic acid (linoleic acid), 5, 8, 11, 5, 8, 11, 14, and 4,7,10,13,16,19-docosahexaenoic acid (DHA) were obtained by preparative-scale high-performance liquid chromatography and analysed for purity (more than 98%) by capillary gas-liquid chromatography at Sagami Chemical Research Center (Kanagawa, Japan). No antioxidants were added to these fatty acid preparations, which were stored in sealed ampoules (15 ml each) containing nitrogen gas at -20°C in the *Present address: Department of Urology, University of Tsukuba, Tennoudai, Tsukuba, Ibaragi, Japan 
Treatment with acetylsalicylic acid and indomethacin
To evaluate the additive effects of the anti-inflammatory agents acetylsalicylic acid or indomethacin on the ability of PUFAs to influence spontaneous lung metastasis, DHA and linoleic acid (0.1 ml per mouse) were administered p.o. daily from day 5 for 3 weeks (5 days per week from Monday to Friday) and acetylsalicylic acid (50 and 100 mg kg-') or indomethacin (5 and 10 mg kg-1) were administered i.v. on days 10, 17 and 24 or orally five times a week from days 5 to 27. All mice were killed on day 28 and investigated for macroscopic lung metastases as described above.
Intravenous injection of tumour cells obtained from mice treated with fatty acids
To assess directly the effects of PUFAs on the metastatic ability of Co 26Lu cells, tumour-bearing mice (five mice per group) were administered daily either oleic acid, linoleic acid, EPA or DHA (0.1 ml per mouse) from days 5 to 14 by gastric tube. They were killed by cervical dislocation 24 h after the last treatment (day 15), and their tumours were rapidly excised, minced with scissors, pressed through 120 wire mesh using a pestle of syringe and saline and finally adjusted to 3 x l05 cells per ml. 
Plasma and tumour samples for fatty acid analysis
To determine the fatty acids content in the plasma and tumour tissues, tumour-bearing CDF1 mice (five mice per group) were administered daily either oleic acid, linoleic acid, EPA or DHA (0.1 ml per mouse) from days 5 to 14 by gastric tube. Blood samples were collected under diethyl ether anaesthesia from the descending vena cava at 24 h after the last administration of the unsaturated fatty acids (day 15) and were immediately cooled on ice. The samples were then centrifuged for 10 min at 3500 r.p.m. and plasma was collected. Their tumours were removed and chilled in dry ice-acetone as rapidly as possible. Total lipids were extracted from the plasma and lyophilized tumour tissue using a modification of a previously reported procedure (Bligh and Dyer, 1959) . For this purpose, approximately 10-mg (dry weight) tissue samples were used. The lipids were extracted with 1.5 ml of chloroform-methanol (1:2, v/v), and 0.5 ml each of distilled water followed by chloroform were added. The residual lipids in the aqueous phase were extracted twice with 0.5 ml of chloroform. The extracts were pooled and evaporated to dryness at 37°C under nitrogen.
Methyl esters of fatty acids were formed by adding 1 ml of methanolic hydrochloric acid to the lipid extract in Teflon-coated screw-capped culture tubes for 60 min at 100°C; they were then extracted three times with n-hexane. The organic phase was evaporated under nitrogen, and the extracts were stored at -40C.
Residues were dissolved in 50 gl of n-hexane and the fatty acid methyl esters were isolated by thin-layer chromatography (TLC). TLC plate (no. 5721, Merck, Germany), developed with Effects of acetylsalicylic acid and indomethacin on lung metastasis DHA is known to inhibit cyclo-oxygenase activity (Corey et al, 1983) . The effects of the cyclo-oxygenase inhibitors, acetylsalicylic acid and indomethacin, were therefore investigated. Indomethacin (1 mg kg-' i.p.) and acetylsalicylic acid (100 mg kg-' i.p.) decrease prostaglandin levels in mice (Gupta, 1989) (1997) 75(5) 1.8 ± 0.1a 10.6 0.6a 0.3 ± 0.2 3.1 ± 0.2a 13.9 ± 1.7a 11.1 ± 0.8a DHA 5094 21.2 0.9 7.0 ± 0.2 21.4 0.7 1.6 ± 0.1a 11.0 0.5b 0.6 ± 0.0 2.8 ± 0.3a 2.9 ± 0.2 24.3± 1.7a
Tumour-bearing mice (five mice per group) were treated with unsaturated fatty acids (0.1 ml per mouse) orally once a day for ten consecutive days from day 5. Blood was taken from mice anaesthetized with ethyl ether 24 h after last treatment. The plasma was separated by centrifugation, and the samples were assayed for fatty acids by gas chromatography. aP<0.01 compared with untreated control group; bp<0.05 compared with untreated control group. Italic indicates correspondence with the administered fatty acid. n-6 n-6 n-3 n-3 Tumour-bearing mice (five mice per group) were treated with unsaturated fatty acids orally once a day for ten consecutive days from day 5. The tumours were taken from tumour-bearing mice 24 h after last treatment and were immediately frozen; the samples were then assayed for fatty acids by gas chromatography.
aP<0.01 compared with untreated control group; bp<Q.05 compared with untreated control group. Italic indicates correspondence with the administered fatty acid.
lung colonies compared with their untreated counterparts. In particular, tumour cells treated with DHA showed a marked decrease in their lung colony-forming ability (P<0.01) compared with those exposed to EPA or linoleic acid.
Changes in fatty acid contents in plasma and tumour tissue following oral administration of PUFA As shown in Table 4 , oral administration of unsaturated fatty acids produced a decrease in the total fatty acids in the plasma. The arachidonic acid contents increased following administration of either arachidonic acid or linoleic acid and decreased following administration of oleic acid, EPA or DHA. Administration of EPA or DHA also caused elevations of their contents. In addition, a slight increase in EPA was observed following DHA administration, and a slight decrease in DHA was noted following linoleic acid and arachidonic acid administration. In Co 26Lu tumour tissue (Table 5) , total fatty acids did not change markedly except after DHA and oleic acid administration. Oleic acid constituted 40% of the total fatty acids. Arachidonic acid contents were low, following the administration of DHA. The EPA contents were very low, except after administration of EPA and DHA. DHA increased following administration of EPA and DHA. Accordingly, administration of unsaturated fatty acid altered the contents of fatty acids in tumour tissues. In particular, exposure to DHA caused marked changes in constituents.
DISCUSSION
EPA and DHA did not show any inhibition of tumour growth and metastases in animals fed a normal diet rich in linoleic acid. In this study, using the AIN93M(c) diet, in which linoleic acid content was markedly reduced, DHA and EPA, especially at high doses, significantly inhibited the growth of the highly metastatic colon carcinoma Co 26Lu, as well as lowering the numbers of lung metastatic colonies. On the other hand, linoleic acid exerted an enhancing effect on metastasis at high doses.
Mammary tumour cells with a high capacity for metastasis have been reported to contain elevated levels of prostaglandins compared with their poorly metastatic counterparts (Fulton and Heppner, 1985) . The eicosanoid content of tissues may clearly be influenced by the fatty acid constituents of the dietary fats consumed by the host animal. Linoleic acid and n-6 PUFAs are major sources of arachidonic acid, which is further metabolized to prostaglandins and leukotrienes by reactions catalysed by cyclo-oxygenase and lipoxygenase respectively. While DHA is known to inhibit cyclooxygenase activity (Corey et al, 1983) , the failure in the present study of acetylsalicylic acid and indomethacin, which reduce prostaglandin levels (Gupta, 1989) , to inhibit the formation of lung metastatic nodules, either alone or following administration of linoleic acid or DHA, suggests that the inhibition of metastasis observed for fatty acids is not dependent on their influence on production of prostaglandins. In addition, administration of arachidonic acid itself did not result in any enhancing effect on metastasis to the lung, despite the increase in this n-6 fatty acid in tumour tissue. The results thus indicate that prostaglandin content does not correlate with formation of metastatic nodules in this tumour system.
The effects of PUFAs have been shown to be selective for cancer cells without affecting normal cells in vitro (Begin et al, 1986) . EPA, in particular, has been reported to significantly inhibit the growth of human pancreatic cancer cell lines in vitro (Falconer et al, 1994) , and this effect appears to be associated with the generation of lipid peroxides (Begin et al, 1985) . In Co 26Lu culture cells in RPMI-1640 containing 10% fetal bovine serum (FBS), IC 50 values for treatment with EPA and DHA were all about 50 l.M, whereas values for oleic acid and linoleic acid were over 100 ltM after 6 days' exposure. There were no large differences between EPA and DHA. In our in vivo study, oral administration of EPA and DHA before or after the injection of tumour cells into a tail vein did not significantly inhibit lung colonization so that a simultaneous presence appears to be of importance. Incorporation of EPA and DHA may yield lipid peroxides, which can kill the tumour cells. However, the effect of oleic acid cannot be simply explained by the same mechanism and requires further investigation.
The ability of tumour cells to metastasize has been shown to depend on the fatty acid composition of the cell membrane and reflect the dietary fat intake (Cave and Erickson-Lucas, 1982; Cohen et al, 1986) . Cells are modified by the fatty acid constituents of the culture medium in vitro (Wicha et al, 1979; Ginsberg et al, 1982) , and membranes rich in linoleic acid exhibit high fluidity (Ginsberg et al, 1982; Taraboletti et al, 1989) . In murine tumour cell lines, a relationship exists between metastatic ability and the lipid composition of the cell membrane, with linoleic acid playing an important role (Kier and Franklin, 1991) . Different contents of oleic acid and arachidonic acid have been noted between primary and metastatic tumours (Kier et al, 1988) . In metastatic variants of a series of human prostatic adenocarcinoma cell lines, the arachidonic acid level was found to be significantly decreased (Dahiya et al, 1992) . However, in our study, tumour cells obtained from the hosts administered EPA or DHA demonstrated decreases in both arachidonic acid contents and metastatic ability. Moreover, i.v. injection of tumour cells with a greatly increased content of linoleic acid did not result in any increase in lung metastatic nodules. Administration of large amounts of fatty acids (0.2 ml) caused toxicity, and this was associated with some reduction in the inhibitory effects on lung metastatic nodules, presumably owing to an impaired host defence system, such as inhibition of macrophage activation by DHA (Dustin et al, 1990 ). In conclusion, the present data suggest that fatty acid composition of tumour cell membrane is an important factor with relevance to metastatic potential. An increase in n-3 PUFAs, such as EPA and DHA, appears to reduce these features of malignancy without necessarily blocking prostaglandin synthesis. The present model should allow light to be cast on the mechanisms underlying this beneficial influence.
